TK Nucera stock trades around recent low as hydrogen order intake and revenue development draw attention

TK Nucera (ISIN DE000NCA0001) stock has been trading close to its recent 52 week low in 2024, while the company continues to report growing order intake and rising revenue from its hydrogen electrolysis business according to its latest published financial figures for 2023 and early 2024. This contrast between a weak share price and expanding operational scale is central for investors assessing the company in 2024.

Revenue growth and order intake in 2023

According to TK Nucera’s published financial information for fiscal 2023, the company reported revenue in the low hundreds of millions of euros, higher than in 2022, showing that commercial projects in alkaline water electrolysis and chlor alkali systems have started to scale. The reported 2023 revenue level marked a clear year on year increase compared with 2022, underlining that the company is moving from demonstration projects toward larger industrial references.

The same 2023 information showed that TK Nucera’s order intake rose further above the revenue line, indicating a growing backlog of hydrogen related projects that are expected to be executed over the following years. This backlog, also in the hundreds of millions of euros, provides medium term revenue visibility and is an important factor for investors who look at the company’s growth path in the emerging green hydrogen market. Management also highlighted that a large share of these orders comes from large scale industrial customers in Europe and other regions planning gigawatt scale electrolysis installations.

While revenue and order intake increased in 2023, profitability remained under pressure because TK Nucera continued to invest heavily in technology, project development capabilities, and global expansion. Earnings before interest and taxes for 2023 stayed negative, illustrating that the company is still in an early growth phase where upfront costs and project preparation outweigh the margins from the projects that have already been delivered.

Hydrogen margins and 2024 trajectory

In the latest available quarterly update for 2024, TK Nucera reported that revenue for the period was again above the comparable period of 2023, continuing the growth trend that started after its spin off. The reported growth rate between the 2024 period and the same period in 2023 was in the double digit percentage range, reflecting a higher volume of electrolysis equipment deliveries and project milestones reached. This ongoing revenue expansion shows that the order backlog from earlier periods is gradually converting into sales.

At the same time, the 2024 update confirmed that margins remain relatively thin or negative because many large hydrogen projects are still in early phases, and the company needs to maintain engineering capacity and R&D spending. Adjusted EBIT in the period remained below zero, although the loss narrowed compared with the prior year quarter as higher revenue helped to cover fixed costs. This narrowing loss suggests that TK Nucera is gradually moving toward breakeven as its project pipeline scales and as learning curves and economies of scale begin to take effect.

For the full year 2024, the company has guided for revenue clearly above the 2023 level and for an improvement in adjusted EBIT compared with the previous year, while still expecting that heavy investment in future growth will weigh on profitability. Guidance points to continued high order intake in the alkaline water electrolysis segment, as industrial customers advance their plans to decarbonize processes such as steelmaking, chemicals, and refining.

Electrolyzer portfolio for green hydrogen

TK Nucera’s core business is the development and delivery of large scale alkaline water electrolysis systems and chlor alkali technology that convert renewable electricity into hydrogen. The company positions its electrolyzers as modular blocks that can be combined into plants with capacities from tens of megawatts up to gigawatt scale, addressing demand from sectors like steel, ammonia, and fuel production. Its proprietary cell technology builds on decades of experience in chlor alkali electrolysis, which is being transferred into green hydrogen applications.

In addition to selling equipment, TK Nucera also offers engineering, procurement, and construction services as well as long term service and maintenance contracts for its electrolyzer installations. These additional services create recurring revenue streams over the lifetime of a hydrogen plant and can support margins once the installed base reaches a higher level. The company has stated that it is working with partners and customers in Europe, the Middle East, and other regions to develop flagship projects that can serve as references for further rollouts.

TK Nucera stock and valuation context

TK Nucera stock, listed in euros on the German market via its ISIN DE000NCA0001, currently trades near its 52 week low in 2024, even though the company’s order intake and revenue have been rising year on year. This means the implied valuation multiple on expected future revenue is lower than at the time of its initial listing, reflecting a more cautious market stance toward early stage hydrogen equipment providers. For investors, the key question is how quickly the company can convert its backlog into profitable revenue and how stable the policy framework for green hydrogen will remain in Europe and globally.

Compared with more diversified industrial groups that also offer hydrogen technologies, TK Nucera is much more focused on alkaline electrolysis equipment, which makes its stock more sensitive to news around hydrogen project approvals, subsidies, and financing conditions. If large planned projects are delayed, this can affect revenue timing and potentially lead to periods where capacity is underutilized. On the other hand, successful execution of a few very large reference plants can significantly increase confidence in the technology and improve the company’s negotiating position in future tenders.

Liquidity in TK Nucera stock is typical for a mid cap technology company listed in Germany. Daily trading volumes allow institutional investors to build or adjust positions, but the share price can still react with noticeable percentage moves to larger orders or to news about major hydrogen policy developments. For now, the market appears to be pricing in both the growth opportunity and the execution risk inherent in a company that is building out a new industrial technology segment.